The Net Margin of Suven Pharmaceuticals Ltd (SUVENPHAR.NS) is 28.56%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-03-31 | 28.56% |
| 2023-03-31 | 30.69% |
| 2022-03-31 | 34.37% |
| 2021-03-31 | 35.88% |
| 2020-03-31 | 38.02% |
| 2019-03-31 | 28.93% |